National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.

Lars Ehlers; Wilhelmina Maria Müskens; Lotte Groth Jensen; Mette Kjølby; Grethe Andersen
The purpose of this analysis was to assess the budgetary impact and cost effectiveness of the national use of thrombolysis with alteplase (recombinant tissue plasminogen activator; rt-PA) for acute ischaemic stroke via telemedicine in Denmark.

National use of thrombolysis with alteplase for acute ischemic stroke via telemedicine in Denmark

Udgivelsesform Videnskabelige artikler
År 2008
Udgiver CNS Drugs 2008;22(1):73-81.